Secreted Protein Acidic and Rich in Cysteine (SPARC) Inhibits Integrin-Mediated Adhesion and Growth Factor-Dependent Survival Signaling in Ovarian Cancer
- 1 March 2007
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 170 (3) , 1054-1063
- https://doi.org/10.2353/ajpath.2007.060903
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Role of Integrin Receptors for Fibronectin, Collagen and Laminin in the Regulation of Ovarian Carcinoma Functions in Response to a Matrix MicroenvironmentClinical & Experimental Metastasis, 2005
- Integrin signalling during tumour progressionNature Reviews Molecular Cell Biology, 2004
- Aggregation of Integrins and RhoA Activation Are Required for Thy-1-induced Morphological Changes in AstrocytesJournal of Biological Chemistry, 2004
- Heparin-Binding EGF-Like Growth Factor Is a Promising Target for Ovarian Cancer TherapyCancer Research, 2004
- SPARC and tumor growth: Where the seed meets the soil?Journal of Cellular Biochemistry, 2004
- Cell-Free 59 kDa Immunoreactive Integrin-Linked KinaseClinical Cancer Research, 2004
- Integrin activationJournal of Cell Science, 2004
- αv integrins regulate cell proliferation through integrin-linked kinase (ILK) in ovarian cancer cellsOncogene, 2003
- SPARC (Secreted Protein Acidic and Rich in Cysteine) Induces Apoptosis in Ovarian Cancer CellsThe American Journal of Pathology, 2001
- Integrins can collaborate with growth factors for phosphorylation of receptor tyrosine kinases and MAP kinase activation: roles of integrin aggregation and occupancy of receptors.The Journal of cell biology, 1996